Everest Medicines Limited (HKG: 1952)

Everest Medicines Revenue

Everest Medicines had revenue of 301.52M CNY in the half year ending June 30, 2024, with 28,780.94% growth. This brings the company's revenue in the last twelve months to 418.55M, up 1,927.58% year-over-year. In the year 2023, Everest Medicines had annual revenue of 125.93M with 884.46% growth.

• Revenue (ttm): 418.55M CNY
• Revenue Growth: +1,927.58%
• P/S Ratio: n/a
• Revenue / Employee: 968.88K CNY
• Employees: 432
• Market Cap: 14.95B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	125.93M	113.14M	884.46%
Dec 31, 2022	12.79M	12.74M	23,588.89%
Dec 31, 2021	54.00K	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-